Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Venus Concept Inc. - 8-K, Current Report | 2 | SEC Filings | ||
20.06. | Venus Concept files to sell 899,870 shares of common stock by selling shareholders | 1 | Seeking Alpha | ||
20.06. | Venus Concept Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
09.06. | Venus Concept Inc.: Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | 1 | GlobeNewswire (USA) | ||
VENUS CONCEPT Aktie jetzt für 0€ handeln | |||||
06.06. | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
06.06. | Venus Concept To Sell Venus Hair Business To Meta Healthcare For $20M In All-Cash Deal | - | RTTNews | ||
06.06. | Venus Concept prices $3.45M in direct offering, warrants; shares up over 29% | 4 | Seeking Alpha | ||
06.06. | Venus Concept secures $1.15 million in direct offering | 1 | Investing.com | ||
06.06. | Venus Concept sichert sich 1,15 Millionen US-Dollar durch Direktplatzierung | 1 | Investing.com Deutsch | ||
06.06. | Venus Concept Inc.: Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | 1 | GlobeNewswire (USA) | ||
06.06. | Venus Concept sells hair business to MHG for $20 million | 1 | Investing.com | ||
06.06. | Venus Concept Inc.: Venus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 Million | 299 | GlobeNewswire (Europe) | TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today it has entered into a... ► Artikel lesen | |
02.06. | Venus Concept sichert Änderungen der Kreditvereinbarungen zur Verbesserung der Liquidität | 3 | Investing.com Deutsch | ||
28.05. | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
15.05. | Venus Concept signals modest margin impact from tariffs and targets next-gen body device launch in H2 2025 amid challenging capital environment | 1 | Seeking Alpha | ||
15.05. | Venus Concept Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
15.05. | Venus Concept GAAP EPS of -$17.44, revenue of $13.64M | 2 | Seeking Alpha | ||
15.05. | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
15.05. | Venus Concept Inc.: Venus Concept Announces First Quarter 2025 Financial Results | 84 | GlobeNewswire (Europe) | TORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three... ► Artikel lesen | |
02.05. | Venus Concept Inc. - 8-K, Current Report | 2 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ECKERT & ZIEGLER | 68,00 | +2,26 % | Leichte Zugewinne bei der Eckert&Ziegler-Aktie (65,60 €) | Die Eckert&Ziegler-Aktie notiert heute etwas fester. Das Wertpapier kostete zuletzt 65,60 Euro. Eine Verteuerung in Höhe von 1,75 Euro erfreut derzeit die Aktionäre von Eckert&Ziegler. Zur Stunde kostet... ► Artikel lesen | |
UNITEDHEALTH | 260,50 | +0,75 % | Dividendenbekanntmachungen (24.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) COMPAGNIE DE L ODET SA FR0000062234 - 4,4 EUR DOM DEVELOPMENT SA PLDMDVL00012 7 PLN 1,6374 EUR ELBIT SYSTEMS LTD IL0010811243 0... ► Artikel lesen | |
TELADOC HEALTH | 7,410 | +7,67 % | Aktien-Trading 4 Dummies - 3 Aktien. 2 Experten. 0 Langeweile (Hims & Hers, Teladoc & XTI Aerospace) | ||
THERMO FISHER | 350,85 | -0,38 % | Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply | Scope of Agreement with Cambrex to Provide Ondansetron HCL Drug Substance Under FDA Approved Drug Master File Scope Of Agreement With Thermo Fisher to Provide Manufacturing Services Including Demonstration... ► Artikel lesen | |
ROKU | 73,78 | -0,18 % | This 30-second fix made my Roku TV run like new again (and why it works) | ||
BICO GROUP | 3,222 | -0,49 % | Bico Group Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
SERNOVA BIOTHERAPEUTICS | 0,105 | -1,87 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
PLUS THERAPEUTICS | 0,323 | -11,42 % | Plus Therapeutics Expects Meaningful Revenue Contributions From CNSide Diagnostics In 2026 | WASHINGTON (dpa-AFX) - Plus Therapeutics, Inc. (PSTV), a clinical-stage pharmaceutical company, expects the revenue contributions of CNSide Diagnostics, LLC to 'become meaningful' in fiscal... ► Artikel lesen | |
RESMED | 220,00 | +0,46 % | ResMed-Aktie: Kurs steigt nur geringfügig (220,1782 €) | An der US-amerikanischen Börse ist die Aktie von ResMed zur Stunde unauffällig. Der jüngste Kurs betrug 254,22 US-Dollar. Kaum verändert im Vergleich zu der Schlussnotierung vom Vortag zeigt sich aktuell... ► Artikel lesen | |
HENRY SCHEIN | 62,74 | +0,35 % | Is Henry Schein Stock Outperforming the Dow? | ||
ATOSSA THERAPEUTICS | 0,738 | -0,81 % | Atossa Genetics Year-end 2024 slides: (Z)-endoxifen shows promise, expenses decline | ||
PING AN HEALTHCARE | 0,946 | +9,49 % | PA GOODDOCTOR (01833): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 JUNE 2025 | ||
EVOFEM BIOSCIENCES | - | - | Windtree Therapeutics: Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel | Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,400 | -0,94 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
FRESENIUS | 42,440 | +0,59 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
20.06.2025 /... ► Artikel lesen |